✦ LIBER ✦

CHEK2 1100delC mutation is frequent among Russian breast cancer patients

✍ Scribed by Elena V. Chekmariova; Anna P. Sokolenko; Konstantin G. Buslov; Aglaya G. Iyevleva; Yulia M. Ulibina; Maxim E. Rozanov; Natalia V. Mitiushkina; Alexandr V. Togo; Dmitry E. Matsko; Dmitry A. Voskresenskiy; Oleg L. Chagunava; Peter Devilee; Cees Cornelisse; Vladimir F. Semiglazov; Evgeny N. Imyanitov

Book ID: 106377125
Publisher: Springer US
Year: 2006
Tongue: English
Weight: 176 KB
Volume: 100
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-006-9227-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CHEK2c.1100delC mutation among non-BRCA1

CHEK2c.1100delC mutation among non-BRCA1/2Spanish hereditary breast cancer families

✍ L. Fachal, M. Santamariña, A. Blanco, Á. Carracedo, A. Vega 📂 Article 📅 2012 🏛 Springer Milan 🌐 Spanish ⚖ 216 KB

Frequency of the CHEK2 1100delC mutation

Frequency of the CHEK2 1100delC mutation among women with early-onset and bilateral breast cancer

✍ Dapeng Ding, Ying Zhang, Xiaofeng He, Wei Meng, Wenli Ma, Wenling Zheng 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 80 KB

CHEK2 1100delC is prevalent in Swedish e

CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer

✍ Sara Margolin; Hans Eiberg; Annika Lindblom; Marie Luise Bisgaard 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 272 KB

Excess Risk for Contralateral Breast Can

Excess Risk for Contralateral Breast Cancer in CHEK2*1100delC Germline Mutation Carriers

✍ Annegien Broeks; Lot de Witte; Anke Nooijen; Angelina Huseinovic; Jan G.M. Klijn 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 48 KB

Correlation of CHEK2 protein expression

Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients

✍ Outi Kilpivaara; Jirina Bartkova; Hannaleena Eerola; Kirsi Syrjäkoski; Pia Vahte 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 145 KB

The CHEK2 kinase is a tumor suppressor whose activation in response to DNA double-strand breaks contributes to cell cycle arrest or apoptosis. The c.1100delC mutation is associated with familial breast cancer, and tumors from mutation carriers show reduced or absent CHEK2 protein expression. We have

CHEK2 1100delC is not a risk factor for

CHEK2 1100delC is not a risk factor for male breast cancer population

✍ Kirsi Syrjäkoski; Tuula Kuukasjärvi; Anssi Auvinen; Olli-P Kallioniemi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 50 KB

## Abstract Genetic risk factors for male breast cancer (MBC) are poorly understood. High penetrance genes such as BRCA1 or BRCA2 account for only a small proportion of the disease. A 1100delC mutation in CHEK2 (previously known as CHK2), a cell‐cycle checkpoint kinase, has been implicated in predi